Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients

被引:1
作者
Ahmed, Saima [1 ]
Ahmed, Ejaz [1 ]
Naqvi, Rubina [1 ]
Qureshi, Sehar [1 ]
机构
[1] Sindh Inst Urol & Transplantat, Dept Nephrol, Karachi, Pakistan
关键词
Transplant; Erythrocytosis; Thrombosis; POSTTRANSPLANT ERYTHROCYTOSIS; ALLOGRAFT RECIPIENTS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the prevalence and contributing factors causing post transplant erythrocytosis in renal transplant patients. Methods: This retrospective study was conducted on live related renal transplant patients at SIUT. The records of all transplant recipients transplanted between April 2008 and December 2008 and who had at least 24 months follow up were studied. Patients in whom haematocrit exceeded 51% and those who received treatment for it were classified into post transplant erythrocytosis group. Results: Out of 200 renal transplant patients who had functioning graft at the time of analysis, 40 (20%) developed post transplant erythrocytosis (HCT >= 51%) after a mean interval of 9.5 +/- 2.5 months. Patients with erythrocytosis were mostly males (95% in PTE group vs 73.75% in non PTE group),had a shorter period on dialysis before undergoing renal transplantation (9.28 months in PTE group vs 14.56 months in non PTE group) and had relatively better graft function at the onset of erythrocytosis as judged by serum creatinine (S. Creatinine of 1.06 +/- 0.29mg/dl in PTE group vs 1.37 +/- 0.51 mg/dl in non PTE group). No thrombotic complications were observed. All patients with erythrocytosis were treated with enalapril (ACE inhibitors) and 28 out of 40 required phlebotomy in addition to ACE inhibitors. The mean HCT at the time of last follow up in treated patients was 48.61 +/- 1.85%. Conclusion: Post transplant erythrocytosis generally occurs in male patients with good graft function, thrombotic complications are of rare occurrence and response to ACE inhibitors is good.
引用
收藏
页码:1326 / 1329
页数:4
相关论文
共 15 条
  • [1] Abdelrahman Mohamed, 2004, Saudi J Kidney Dis Transpl, V15, P433
  • [2] EFFECTS OF THEOPHYLLINE ON ERYTHROPOIETIN PRODUCTION IN NORMAL SUBJECTS AND IN PATIENTS WITH ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION
    BAKRIS, GL
    SAUTER, ER
    HUSSEY, JL
    FISHER, JW
    GABER, AO
    WINSETT, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (02) : 86 - 90
  • [3] BARENBROCK M, 1993, CLIN NEPHROL, V40, P241
  • [4] Erythrocytosis after renal transplantation: Review of 101 cases
    Einollahi, B
    Lessan-Pezeshki, M
    Nafar, M
    Pour-Reza-Gholi, F
    Firouzan, A
    Farhangi, F
    Pourfarziani, V
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3101 - 3102
  • [5] Factors relating to posttransplant erythrocytosis in renal allograft recipients
    Ghahramani, NL
    Malek-Hosseini, SA
    Rais-Jalali, GA
    Behzadi, S
    Nezakatgoo, N
    Salahi, H
    Javid, R
    Rad, SB
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (03) : 828 - 829
  • [6] Gruber SA, 2004, CLIN TRANSPL, V2, P433
  • [7] Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence
    Hiremath, S.
    Fergusson, D.
    Doucette, S.
    Mulay, A. V.
    Knoll, G. A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (10) : 2350 - 2360
  • [8] Post-transplant erythrocytosis and thromboembolic events: an error
    Kazory, A
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (01) : 260 - 260
  • [9] Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients
    Kedzierska, Karolina
    Kabat-Koperska, Joanna
    Safranow, Krzysztof
    Domanski, Maciej
    Golembiewska, Edyta
    Bober, Joanna
    Bohatyrewicz, Romuald
    Ciechanowski, Kazimierz
    [J]. CLINICAL TRANSPLANTATION, 2008, 22 (02) : 156 - 161
  • [10] Use of aminophylline and enailapril in posttransplant polycythemia
    Mazzali, M
    Alves, G
    [J]. TRANSPLANTATION, 1998, 65 (11) : 1461 - 1464